Damartex (ALDAR)
Euronext Paris · France · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 2.300 |
|---|---|
| 52-week range | 1.890 – 4.300 |
| Return, 1 month / 3 months | −4.6% / −6.1% |
| Return, 1 year / 3 years | −40.7% / −57.4% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 34.6% |
| Worst drawdown (1 year) | -53.5% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Damartex is a French retail group that serves older customers through clothing and home-care brands. Its Damart business designs and sells thermal underwear, knitwear and everyday apparel aimed at people who feel the cold, while other group brands offer home textiles, comfort footwear and independent-living products. The company sells through catalogues, websites and shops, mainly in France and other European countries, and is based in the north of France.
The shares are listed on the Euronext Paris in France under the code ALDAR, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Damartex (ALDAR) trades on the Euronext Paris in France. It last closed at EUR 2.300 on 22 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 430 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 40.7% and over the last three months it fell 6.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.4% | ||
| From 52-week high | -46.5% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.1% | ||
| 6-month return | -2.5% | ||
| 12-month return, skipping the last month | -37.9% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -53.5% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | −4.6% |
| 3 months | −6.1% |
| 6 months | −2.5% |
| 1 year | −40.7% |
| 3 years | −57.4% |
| 5 years | −88.7% |
Signals
| 50-day / 200-day average | 2.440 / 2.485 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.032 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Dec 2022 | EUR 0.1000 |
| 26 Nov 2021 | EUR 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.